PHARMA DESIGN & DEVELOPMENT LIMITED
Warning: The most recent accounts from 31 January 2020 indicate this Company is Dormant and not currently trading
Company Documents
Date | Description |
---|---|
30/01/2130 January 2021 | ACCOUNTS OF DORMANT COMPANY MADE UP TO 31/01/20 |
06/02/206 February 2020 | CONFIRMATION STATEMENT MADE ON 06/02/20, NO UPDATES |
31/01/2031 January 2020 | Annual accounts for year ending 31 Jan 2020 |
17/10/1917 October 2019 | ACCOUNTS OF DORMANT COMPANY MADE UP TO 31/01/19 |
21/02/1921 February 2019 | APPOINTMENT TERMINATED, DIRECTOR PHILIP GOSTLING |
21/02/1921 February 2019 | DIRECTOR APPOINTED MRS JOANNE HELEN GOSTLING |
21/02/1921 February 2019 | CONFIRMATION STATEMENT MADE ON 21/02/19, WITH UPDATES |
21/02/1921 February 2019 | NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL JOANNE HELEN GOSTLING |
21/02/1921 February 2019 | CESSATION OF PHILIP JOHN GOSTLING AS A PSC |
08/02/198 February 2019 | CONFIRMATION STATEMENT MADE ON 21/01/19, NO UPDATES |
31/01/1931 January 2019 | Annual accounts for year ending 31 Jan 2019 |
17/01/1917 January 2019 | REGISTERED OFFICE CHANGED ON 17/01/2019 FROM UNIT 1, UNION BUSINESS PARK SNAYGILL INDUSTRIAL ESTATE SKIPTON NORTH YORKSHIRE BD23 2QR UNITED KINGDOM |
02/07/182 July 2018 | COMPANY NAME CHANGED NORVAP PHARMA LIMITED CERTIFICATE ISSUED ON 02/07/18 |
22/01/1822 January 2018 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company